Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma

Authors:

Abstract
Significance: Glioblastoma (GBM) cells develop intrinsic or acquired insensitiveness to BET bromodomain inhibitors (BBIs) yet develop persistent BET protein dependency. Selective degradation of BET proteins by a next-generation chemical compound undermines the BET protein dependency and exerts superior antineoplastic effects over inhibition of BET bromodomain. Given the significant difference between bromodomain dependency and BET protein dependency in GBM cells, chemically induced degradation of BET proteins serves as a promising strategy to overcome anticipated clinical BBIs resistance.
Funding Information
  • National Research Foundation Singapore (NMRC/STaR/0021/2014)
  • Ministry of Education - Singapore (MOE2013-T2-2-150)
  • Ministry of Education - Singapore (MOE2017-T2-1-033)
  • MOH | National Medical Research Council (NMRC/TCR/016-NNI/2016)
  • Damon Runyon Cancer Research Foundation (DRG-2196-14)